Embryonal Rhabdomyosarcoma: A Case Report on A 2 Months-Old Infant

Rhabdomyosarcoma (RMS) is an aggressive malignant neoplasma of the musculoskeletal system that represents 50% of all soft tissue sarcoma in children. Rhabdomyosarcoma is the most common soft tissue sarcoma in children, while the majority of rhabdomyosarcoma cases occurs in children under the age of 6 years old, RMS is uncommon in infants. Since there is no clear evidence that the biology of RMS itself is different in infants, the reason for a poorer prognosis is unclear. This case report aims to further examine the pathological features, diagnosis and treatment for embryonal rhabdomyosarcoma. We present a case of a 2 months-old infant with post biopsy inci- sion 12 days prior to hospital admission which is then reffered to the oncologist for further obser- vation. An anatomy pathological examination was done, observed from a 2 x 0,5 x 0,5 brown firm sample which was then revealed as embryonal rhabdomyosarcoma.

Institutions

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-08-07
DOI
https://doi.org/10.5281/zenodo.16810884
Primary Topic
Sarcoma Diagnosis and Treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Embryonal Rhabdomyosarcoma: A Case Report on A 2 Months-Old Infant

Zenodo (CERN European Organization for Nuclear Research)
Sarcoma Diagnosis and Treatment
article

Embryonal Rhabdomyosarcoma: A Case Report on A 2 Months-Old Infant

article en

Abstract

Rhabdomyosarcoma (RMS) is an aggressive malignant neoplasma of the musculoskeletal system that represents 50% of all soft tissue sarcoma in children. Rhabdomyosarcoma is the most common soft tissue sarcoma in children, while the majority of rhabdomyosarcoma cases occurs in children under the age of 6 years old, RMS is uncommon in infants. Since there is no clear evidence that the biology of RMS itself is different in infants, the reason for a poorer prognosis is unclear. This case report aims to further examine the pathological features, diagnosis and treatment for embryonal rhabdomyosarcoma. We present a case of a 2 months-old infant with post biopsy inci- sion 12 days prior to hospital admission which is then reffered to the oncologist for further obser- vation. An anatomy pathological examination was done, observed from a 2 x 0,5 x 0,5 brown firm sample which was then revealed as embryonal rhabdomyosarcoma.

Zenodo (CERN European Organization for Nuclear Research)
Jenderal Soedirman University (ID), Rumah Sakit Dokter Soetomo (ID)
No poverty
Openalex Percentile: Top 37%
Sarcoma Diagnosis and Treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Embryonal Rhabdomyosarcoma: A Case Report on A 2 Months-Old Infant · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS